<DOC>
	<DOCNO>NCT02755545</DOCNO>
	<brief_summary>The purpose study evaluate efficacy 2 acne treatment 24 week use adult men woman mild moderate facial acne , least 5 inflammatory lesion , least 10 - 100 non-inflammatory lesion . Objective : 1 . To characterize effectiveness acne treatment lesion count week 1 , week 2 , week 6 , week 12 , week 24 compare baseline compare treatments 2 . To characterize effectiveness acne treatment Investigator 's Global Improvement Assessment week 1 , week 2 , week 6 , week 12 , week 24 compare baseline compare treatments 3 . To characterize effect acne treatment clinical grading efficacy parameter digital image week 6 , week 12 , week 24 compare baseline compare treatments 4 . To characterize effect acne treatment subject self-assessment questionnaire response week 1 , week 2 , week 6 , week 12 , week 24 compare baseline compare treatment</brief_summary>
	<brief_title>A Clinical Trial Evaluate Efficacy Two Acne Treatments</brief_title>
	<detailed_description />
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<criteria>Key 1 . Men woman age 21 45 year time enrollment . 2 . Individuals mild moderate acne ( score 23 FDA Investigator 's Global Assessment Scale1 ) face . 3 . Individuals least 5 inflammatory lesion . 4 . Individuals 10 100 noninflammatory lesion . 5 . Fitzpatrick skin type IVI 6 . Individuals willing provide write informed consent include photo release , Health Insurance Portability Accountability Act ( HIPAA ) , able read , speak , write , understand English . 7 . Willing withhold facial treatment course study 8 . Individuals child bear potential use acceptable method contraception throughout study . 9 . Subjects must stable medication take least 30 day . Key 1 . Individuals diagnose allergy topical acne product . 2 . Individuals condition and/or disease skin Investigator deem inappropriate participation . 3 . Women nurse , pregnant , plan become pregnant study . 4 . Individuals preexist dormant dermatologic condition face opinion Investigator could interfere outcome study . 5 . Individuals use use systemic medication consider affect course acne , specifically , exclusively antibiotics steroid within last 30 day prior entry study . 6 . Individuals currently participate another facial usage study participate clinical trial within 4 week prior inclusion study . 7 . Individuals plan surgery and/or invasive medical procedure course study . 8 . Individuals start hormone replacement therapy ( HRT ) hormones birth control le 3 month prior study entry plan start , stop , change dos HRT hormone birth control study . 9 . Individuals facial sunburn excessive tan facial skin willing avoid daily sun exposure face use tan bed sunless tan product duration study . 10 . Individuals currently take take within last 30 day oral topical prescription medication acne .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>